Cary Street Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Buy
3,475
+285
+9% +$18.7K ﹤0.01% 891
2026
Q1
$227K Buy
3,190
+46
+1% +$3.63K 0.01% 803
2025
Q4
$258K Buy
3,144
+348
+12% +$27.1K 0.01% 766
2025
Q3
$210K Buy
2,796
+221
+9% +$16.5K 0.01% 781
2025
Q2
$191K Sell
2,575
-1,970
-43% -$137K 0.01% 782
2025
Q1
$367K Sell
4,545
-2,391
-34% -$205K 0.01% 603
2024
Q4
$542K Buy
+6,936
New +$590K 0.02% 497

Other funds holding GEHC

Cary Street Partners's GEHC Position: Q2 2026 in Review

Cary Street Partners increased its GE HealthCare (GEHC) stake by 8.9% in Q2 2026, buying an estimated $18.7K and bringing the position to 3,475 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Cary Street Partners first reported a position in GEHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $542K in Q4 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cary Street Partners held 3,475 shares of GE HealthCare worth $222K as of Q2 2026.
  • Cary Street Partners bought 285 GE HealthCare shares in Q2 2026, an estimated $18.7K.
  • GE HealthCare made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #891 holding.
  • Cary Street Partners first reported a position in GE HealthCare in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's GE HealthCare position peaked at $542K in Q4 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.